Novel Implant Protects Joints From Bacterial Infections Using Mussels
A team of researchers developed an implant coating triggering antibiotic release in response to bacterial infection.

Complete the form below to unlock access to ALL audio articles.
Degenerative arthritis is no longer exclusive to the elderly population. According to the National Health Insurance Service report covering the years from 2012 to 2022, there has been a 22.8% increase in the prevalence of degenerative arthritis among people in their 20s and 30s. This rise is attributed to prolonged periods of desk sitting and the excessive lifting of heavy sports equipment, both of which can lead to significant cartilage damage. While artificial joints are a common treatment, bacterial infections have posed challenges. However, a recent study has proposed an intriguing solution involving the use of mussels.
In implant procedures, bacterial infections not only compromise the stability of the implant but also give rise to various complications. Moreover, highly antibiotic-resistant bacteria often lead to recurrent infections even after antibacterial treatment, requiring additional procedures. While there has been active exploration of implant coating materials with antibiotics, numerous challenges have emerged including physical damage to the material during the procedure and potential leakage of antibiotics inside.
Want more breaking news?
Subscribe to Technology Networks’ daily newsletter, delivering breaking science news straight to your inbox every day.
Subscribe for FREEIn this research, the team directed their attention to DOPA1), one of the amino acids found in mussel adhesion proteins. DOPA, crucial for the robust adhesion observed in mussels, forms potent bonds with metal ions. Its interaction with ferrous metal ions is notable because it weakens as the acidity (pH) decreases. Recognizing that bacterial invasion alters the body’s acidity, the team developed a novel implant coating material.
This material contains antibiotics under normal conditions, but in the event of a bacterial infection and subsequent acidification, it releases 70 percent of the antibiotics within eight hours, effectively eliminating the bacteria. Notably, the material exhibits remarkable durability, showcasing immediate antibacterial efficacy even during the bone regeneration phase (approximately four weeks) following the implant procedure.
The quantity of antibiotics discharged by the material corresponds to the extent of bacterial infection, and the researchers additionally validated the antibacterial efficacy of the coating material based on varying bacterial concentrations. Particularly, the bond between DOPA and iron ions showed remarkable resilience to external physical stimuli, rendering it resistant to abrasion and mechanical loads encountered during the implantation process.
Professor Hyung Joon Cha of the POSTECH who led the study expressed his expectation by saying, “The immediate and sustained antimicrobial effect of the adhesive implant coating material has the potential to significantly enhance the success rate of implant procedures.” Professor Yun Kee Jo of the Kyungpook National University added, explaining the significance of the research, “By releasing antibiotics selectively in response to actual need, this could represent a groundbreaking technology in preventing the emergence of superbacteria in the future.”
Reference: Choi HS, Yun J, Jeong Y, Jo YK, Cha HJ. Self-controllable proteinic antibacterial coating with bacteria-triggered antibiotic release for prevention of periprosthetic infection. Biomaterials. 2024;305:122457. doi: 10.1016/j.biomaterials.2023.122457
This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.